Press Conference

最近的媒体报道

阅读以下关于PerkinElmer 的最近文章,请点击标题链接进入媒体网站查看全文。

PerkinElmer与TeakOrigin联合提高食品安全透明度

2017年12月5日,马萨诸塞州沃尔瑟姆,全球领先的PerkinElmer公司宣布与TeakOrigin公司进行合作。PerkinElmer公司一直致力于创建更为健康的世界而不懈努力。TeakOrigin公司集成技术和数据平台,致力于鉴别食品真伪和质量安全。

珀金埃尔默(PerkinElmer)完成收购欧蒙(EUROIMMUN

美国马萨诸塞州沃尔瑟姆(Waltham, MA)-- 2017年12月19日 作为一家为更健康世界努力创新的全球领先企业,珀金埃尔默公司(PerkinElmer, NYSE: PKI)宣布,正式完成对欧蒙医学实验诊断有限公司(EUROIMMUN Medical Laboratory Diagnostics AG)的收购。珀金埃尔默于2017年6月19日宣布签订收购欧蒙医学实验诊断股份公司的最终协议。

Expert view: Innovations in 3D

Physiologically relevant models to evaluate the effects of drug candidates early in the drug discovery and development process are becoming increasingly important to develop.

Stem Cells Show Promise For Treating Autism

ViaCord helped fund a small, but promising study that suggests stem cells from a child’s own cord blood may offer an effective treatment for autism symptoms.

Direct Analysis of Glyphosate in Wine

Experts describe the analysis of glyphosate in wine with no sample preparation using QSight 220 LC-MS/MS system with a ‘Stay Clean’ source.

The Rise of 3D Cell Culture Systems

The development of three-dimensional (3D) cell culture systems has greatly expanded over the past few decades.

A life-saving option

Banking your child’s cord blood could be the smartest thing you’ll ever do.